COVID-19 Vaccines Should Not Be Ordered By Any Company, NAFDAC Warns

The National Agency for Food and Drug Administration and Control
(NAFDAC), on Friday, said COVID-19 vaccines should not be ordered
by any company.

In a statement issued on NAFDAC’s website, Director-General of
the agency, Professor Mojisola Adeyeye, said companies that
manufacture the vaccines “if they are genuine companies know they
have to submit their application to NAFDAC”.

“No government establishment or agencies should order COVID
vaccines without confirming from NAFDAC if the vaccine has been
approved.

“However, NAFDAC is discussing with manufacturers of candidate
COVID-19 vaccines concerning potential Emergency Use Authorization
(EUA), registration or licensing of their product as the case may
be.

“The Agency assures applicants that if Phase 3 clinical data are
very convincing and robust with regards to safety and efficacy, and
the vaccine has been submitted for WHO for Emergency Use Listing,
NAFDAC will welcome the application for Emergency Use Authorisation
in Nigeria.”

The agency also revealed its plans to “use the Traceability with
GS1 technology to monitor the vaccine distribution using the Global
Trade Item Number (GTIN).”

According to NAFDAC, the move is to prevent fake vaccines from
infiltrating the supply chain and to ensure there is no
diversion.

“This effort will create a reliable and predictable supply
chain. The multi-stakeholder technical working group has been
meeting to address different issues, from access to distribution to
traceability (track and trace) of the vaccines to monitoring of
adverse events following immunization,” the statement added.

The National Agency for Food and Drug Administration and Control
(NAFDAC), on Friday, said COVID-19 vaccines should not be ordered
by any company.

In a statement issued on NAFDAC’s website, Director-General of
the agency, Professor Mojisola Adeyeye, said companies that
manufacture the vaccines “if they are genuine companies know they
have to submit their application to NAFDAC”.

“No government establishment or agencies should order COVID
vaccines without confirming from NAFDAC if the vaccine has been
approved.

“However, NAFDAC is discussing with manufacturers of candidate
COVID-19 vaccines concerning potential Emergency Use Authorization
(EUA), registration or licensing of their product as the case may
be.

“The Agency assures applicants that if Phase 3 clinical data are
very convincing and robust with regards to safety and efficacy, and
the vaccine has been submitted for WHO for Emergency Use Listing,
NAFDAC will welcome the application for Emergency Use Authorisation
in Nigeria.”

The agency also revealed its plans to “use the Traceability with
GS1 technology to monitor the vaccine distribution using the Global
Trade Item Number (GTIN).”

According to NAFDAC, the move is to prevent fake vaccines from
infiltrating the supply chain and to ensure there is no
diversion.

“This effort will create a reliable and predictable supply
chain. The multi-stakeholder technical working group has been
meeting to address different issues, from access to distribution to
traceability (track and trace) of the vaccines to monitoring of
adverse events following immunization,” the statement added.